Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03740893
Title PHOENIX DDR/Anti-PD-L1 Trial: A Pre-surgical Window of Opportunity and Post-surgical Adjuvant Biomarker Study of DNA Damage Response Inhibition and/or Anti-PD-L1 Immunotherapy in Patients With Neoadjuvant Chemotherapy Resistant Residual Triple Negative Breast Cancer (PHOENIX)
Acronym PHOENIX
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Institute of Cancer Research, United Kingdom
Indications
Therapies
Age Groups: adult | senior
Covered Countries GBR

Facility Status City State Zip Country Details
Royal Bournemouth Hospital NOT_YET_RECRUITING Bournemouth Dorset BH7 7DW United Kingdom Details
Bristol Haematology and Oncology Centre NOT_YET_RECRUITING Bristol England BS2 8ED United Kingdom Details
King's College Hospital RECRUITING London England SE5 9RS United Kingdom Details
Christie Hospital NHS Trust NOT_YET_RECRUITING Manchester England M20 4BX United Kingdom Details
Belfast City Hospital NOT_YET_RECRUITING Belfast Northern Ireland BT9 7AB United Kingdom Details
Velindre Cancer Center at Velinde Hospital RECRUITING Cardiff Wales CF14 2TL United Kingdom Details
Queen Elizabeth Hospital, University Hospitals Birmingham NHS Trust NOT_YET_RECRUITING Birmingham United Kingdom Details
Guy's and St Thomas' Hospital NHS Foundation Trust RECRUITING London SE1 9RT United Kingdom Details
Weston Park Hospital NOT_YET_RECRUITING Sheffield United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field